Poland· PL-100222890
Zyx
A levocetirizine product containing levocetirizini dihydrochloridum, registered in Poland by Biofarm Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Levocetirizine is registered in 16 of 19 countries.
Countries holding a registration under ATC R06AE09 (levocetirizine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 10 of them publish a price we can compare per daily dose
Levocetirizine · ATC R06AE09
16 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of levocetirizine costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.15 in France to $0.53 in Switzerland — a ×3.4 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Levocetirizine · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.53
- ES Spain$0.34
- IT Italy$0.21
- FR France$0.15
The record
At a glance
URPL (Poland)- Active substance
- Levocetirizini dihydrochloridum
- Manufacturer
- Biofarm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- R06AE09
- ATC class
- Levocetirizine
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 20
3 priced- gtin05909990765096
- gtin05909990765102
- gtin05909990765126
- gtin05907695215021
- gtin0590999076503428 szt.PLN 19.06
- gtin0590769521501456 szt.PLN 33.91
- gtin0590769521526784 szt.PLN 39.35
- gtin05909990764952
- gtin05909990764969
- gtin05909990764976
- gtin05909990764983
- gtin05909990764990
- gtin05909990765003
- gtin05909990765010
- gtin05909990765027
- gtin05909990765041
- gtin05909990765058
- gtin05909990765065
- gtin05909990765072
- gtin05909990765089
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
267 interactions on record for levocetirizine.
Graded by severity as the source publishes them — 264 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levocetirizine · interactions on record
267 records
- 264 moderate
- 3 minor
Most severe, free to view
- MetoclopramideA03FA01moderate
- DimenhydrinatA04AB02moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levocetirizine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALERGIMEDMEDREG s.r.o., Praha
- United Statesallergy reliefWalgreen Company
- SpainARALEVO 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGArafarma Group S.A.
- ItalyLEVOCETIRIZINA AUROBINDOAUROBINDO PHARMA ITALIA S.R.L.
- FinlandAltoralUCB Pharma Oy Finland
- SwitzerlandLevocetirizin Sandoz 5mg, FilmtablettenSandoz Pharmaceuticals AG
- FranceLEVOCETIRIZINE ARROW 5 mg, comprimé pelliculéARROW GENERIQUES
- NetherlandsCetirmar 5 mg tablettenSynthon B.V.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Lecisyn, Lecivriens
- Belgium · Levocetirizin Ab, Levocetirizine Eg
- Bulgaria · Алерцит, Зенаро
- Cyprus · Ebrilon, Xyzal
- Czechia · Alergimed, Analergin Neo
- Germany · Levoceti Abz, Levocetirizin 1 A Pharma
- Denmark · Levocetirizin Glenmark, Levocetirizin Krka
- Estonia · Cezera, Lewojet
- Spain · Aralevo, Levocetirizina Aurovitas Spain
- Finland · Levocetirizin Ratiopharm, Levocetirizin Stada
- France · Levocetirizine Arrow, Levocetirizine Biogaran
- United Kingdom (Northern Ireland) · Levocetirizina Activase, Levocetirizine
- Greece · Contrahist, Levocet
- Croatia · Xyzal
- Hungary · Cezera, Histisynt
- Ireland · Levocetirizine Dihydrochloride Brillpharma (Ireland), Levocetirizine Glenmark
- Italy · Levocetirizina Aurobindo, Levocetirizina Doc Generici
- Lithuania · Cezera, Xyzal
- Luxembourg · Levocetirizine Eg, Xyzall
- Latvia · Xyzal
- Malta · Rinozal, Xyzal
- Netherlands · Cetirmar, Levocetirizine Dihcl Focus Care
- Norway · Xyzal
- Portugal · Dicloridrato De Levocetirizina Ratiopharm, Levocetirizina
- Romania · Cezera, Levocetirizină Terapia
- Slovenia · Cezera, Xyzal
- Slovakia · Alergimed, Cezera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b957db51-9cfc-4821-8f6f-cd37fb278dd0 GET /v1/drugs/b957db51-9cfc-4821-8f6f-cd37fb278dd0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "5 mg",
"packaging": "05909990764952 ¦ Rp ¦ 56400\n7 tabl.\n05909990764969 ¦ Rp ¦ Skasowane ¦ 56407\n7 tabl. w blistrze perforowanym\n05909990764976 ¦ Rp ¦ 56408\n10 tabl.\n05909990764983 ¦ Rp ¦ Skasowane ¦ 56409\n10 tabl. w blistrze\n05909990764990 ¦ Rp ¦ 56410\n14 tabl.\n05909990765003 ¦ Rp ¦ Skasowane ¦ 56411\n14 tabl. w blistrze\n05909990765010 ¦ Rp ¦ 56412\n20 tabl.\n05909990765027 ¦ Rp ¦ Skasowane ¦ 56413\n20 tabl. w blistrze\n05909990765034 ¦ Rp ¦ 56414\n28 tabl.\n05909990765041 ¦ Rp ¦ Skasowane ¦ 56415\n28 tabl. w blistrze\n05909990765058 ¦ Rp ¦ 56416\n30 tabl.\n05909990765065 ¦ Rp ¦ Skasowane ¦ 56417\n30 tabl. w blistrze\n05909990765072 ¦ Rp ¦ 56418\n40 tabl.\n05909990765089 ¦ Rp ¦ 56419\n50 tabl.\n05909990765096 ¦ Rp ¦ 56420\n60 tabl.\n05909990765102 ¦ Rp ¦ 56421\n100 tabl.\n05909990765126 ¦ Rp ¦ Skasowane ¦ 56422\n100 tabl. w blistrze\n05907695215014 ¦ Rp ¦ 85250\n56 tabl.\n05907695215021 ¦ Rp ¦ Skasowane ¦ 85251\n56 tabl. w blistrze\n05907695215267 ¦ Rp ¦ 123196\n84 tabl.",
"substance": "Levocetirizini dihydrochloridum 5 mg",
"common_name": "Levocetirizini dihydrochloridum",
"pl_product_id": "100222890",
"pozwolenie_nr": "16470",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about levocetirizine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.